SCHEDULE: Eventide Asset Management Discloses Evolent Health Stake
Beneficial Ownership Report
Eventide Asset Management, along with Finny Kuruvilla and Robin C. John, reported a 3.5% beneficial ownership stake in Evolent Health, Inc. Class A Common Stock.
Summary
- Eventide Asset Management, LLC, Finny Kuruvilla, M.D., Ph.D., and Robin C. John collectively reported beneficial ownership of 4,086,852 shares of Evolent Health, Inc. Class A Common Stock.
- This ownership represents 3.5% of the Class A Common Stock outstanding.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- Eventide Asset Management, LLC holds sole voting and dispositive power over all 4,086,852 shares.
- Finny Kuruvilla and Robin C. John share voting and dispositive power over the same 4,086,852 shares.
Sentiment
Score: 6
Explanation: The filing is a routine disclosure of beneficial ownership by an institutional investor, Eventide Asset Management, and its principals. While not indicative of operational performance, the presence of an institutional holder can be viewed as a vote of confidence.
Positives
- A significant institutional investor, Eventide Asset Management, has disclosed a substantial stake in Evolent Health, indicating potential confidence in the company.
Negatives
- The reported ownership percentage of 3.5% is below the 5% threshold, suggesting it is not a new activist stake or a major new position requiring a Schedule 13D filing.
Risks
- No specific risks related to Evolent Health, Inc. were disclosed in this beneficial ownership report.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by an institutional investor in a healthcare technology company. It does not provide specific insights into broader industry trends or competitive landscape beyond the fact that an investment firm sees value in the sector.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder's stake in the company.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 08/14/2025 | Signature date of the filing |
Keywords
Evolent Health, EVH, Eventide Asset Management, Finny Kuruvilla, Robin C. John, Schedule 13G, Beneficial Ownership, Class A Common Stock, Investment, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.